Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of $649.23 million as of May 9, 2025. Its market cap has increased by 20.58% in one year.

Market Cap

649.23M

Enterprise Value

638.33M

Revenue

230.13M

Ranking

n/a

PE Ratio

7.58

Stock Price

$47.50

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 418.27M to 649.23M, an increase of 55.22%. That is a compound annual growth rate of 2.10%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	649.23M	17.49%
Dec 30, 2024	552.59M	10.03%
Dec 29, 2023	502.22M	-14.92%
Dec 30, 2022	590.31M	11.34%
Dec 30, 2021	530.19M	-18.41%
Dec 30, 2020	649.82M	25.05%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.67B
Nika Pharmaceuticals	1.02B
Veradigm	761.84M
Tian'an Technology Group	568.98M
Glass House Brands	484.30M
CytoDyn	482.88M
Elite Pharmaceuticals	448.25M
Northwest Biotherapeutics	390.49M

Market Cap Rankings